68 related articles for article (PubMed ID: 3274773)
1. Persistent expression of donor antigens in endothelium of long-standing skin xenografts and vulnerability to destruction by specific antibodies.
Bogman MJ; de Waal RM; Koene RA
Transplant Proc; 1987 Feb; 19(1 Pt 1):205-7. PubMed ID: 3274773
[No Abstract] [Full Text] [Related]
2. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
[No Abstract] [Full Text] [Related]
3. Analysis of rejection mechanism in the rat to mouse cardiac xenotransplantation. Role and characteristics of anti-endothelial cell antibodies.
Matsumiya G; Shirakura R; Miyagawa S; Izutani H; Sawa Y; Nakata S; Matsuda H
Transplantation; 1994 Jun; 57(11):1653-60. PubMed ID: 8009600
[TBL] [Abstract][Full Text] [Related]
4. Expression of major histocompatibility complex (MHC) antigens on vascular endothelium of spontaneously tolerated liver allografts.
Fabiani B; Astarcioglu I; Guggenheim J; Tricottet V; Bismuth H; Reynès M
Transplant Proc; 1989 Feb; 21(1 Pt 1):407-8. PubMed ID: 2650162
[No Abstract] [Full Text] [Related]
5. Mechanism of rejection of MHC class I-disparate murine skin grafts--histological and immunohistochemical studies of the rejection phenomenon.
Kobayashi E; Kawai K; Ito M; Matsumoto Y; Fujiwara M
Transplant Proc; 1990 Oct; 22(5):2352-7. PubMed ID: 2219400
[No Abstract] [Full Text] [Related]
6. Sensitivity of long-standing xenografts of rat hearts to humoral antibodies.
Burdick JF; Russell PS; Winn HJ
J Immunol; 1979 Oct; 123(4):1732-5. PubMed ID: 383839
[TBL] [Abstract][Full Text] [Related]
7. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
Koch U; Choksi S; Marcucci L; Korngold R
J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
[TBL] [Abstract][Full Text] [Related]
8. Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
Bemelman F; Yong SL; Tissingh R; Schellekens P; ten Berge I
Transpl Int; 2005 Apr; 18(4):423-8. PubMed ID: 15773962
[TBL] [Abstract][Full Text] [Related]
9. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
10. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
Wecker H; Grusby MJ; Auchincloss H
Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
[No Abstract] [Full Text] [Related]
11. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
[TBL] [Abstract][Full Text] [Related]
12. Anti-L3T4 monoclonal antibodies prolong survival of Ia-antigen disparate skin allografts.
Holán V
Folia Biol (Praha); 1988; 34(2):65-71. PubMed ID: 3294049
[TBL] [Abstract][Full Text] [Related]
13. T-cell recognition of donor class I major histocompatibility complex peptides during allograft rejection.
Fangmann J; Dalchau R; Sawyer GJ; Priestley CA; Fabre JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):187-8. PubMed ID: 8438268
[No Abstract] [Full Text] [Related]
14. Class II antigen expression on vascular endothelium of the graft in rat heart transplantation.
Bouwman E; IJzermans JN; Heineman E; de Bruin RW; Marquet RL; Jeekel J
Transplant Proc; 1987 Feb; 19(1 Pt 1):198-9. PubMed ID: 3152687
[No Abstract] [Full Text] [Related]
15. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2.
Gorczynski RM; Fu XM; Issekutz T; Cohen Z
Cell Immunol; 1998 Feb; 184(1):74-82. PubMed ID: 9626338
[TBL] [Abstract][Full Text] [Related]
16. Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation.
Jeyarajah DR; Schmeisser FS; Kadakia RA; Thistlethwaite JR
Transplant Proc; 1994 Jun; 26(3):1201-2. PubMed ID: 8029886
[No Abstract] [Full Text] [Related]
17. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies.
Isobe M; Suzuki J; Yagita H; Okumura K; Yamazaki S; Nagai R; Yazaki Y; Sekiguchi M
J Immunol; 1994 Dec; 153(12):5810-8. PubMed ID: 7527450
[TBL] [Abstract][Full Text] [Related]
18. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
Chen Z; Cobbold SP; Waldmann H; Metcalfe SM
Transplant Proc; 1994 Jun; 26(3):1199-200. PubMed ID: 8029885
[No Abstract] [Full Text] [Related]
19. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
20. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
